Sanofi ($SNY) is rejigging its commercial operations, with two new executive vice presidents stepping up to the plate to replace the retiring global operations President Hanspeter Spek. Peter Guenter will take over global commercial operations, while Pascale Witz, joining Sanofi from GE Healthcare, will handle several divisions, including diabetes, while collaborating with R&D and helping prepare for new drug launches. Release